Earnings Deluge Push Markets Up
The S&P 500 rose Thursday as Wall Street digested recent quarterly results from a slew of megacap tech companies. Investors are coming off a losing session after the Federal Reserve held steady on rates.The Dow Jones Industrials popped 111.75 points to 44,825.27, weighed down by a 4% slide in Caterpillar.The much-broader index gained 19.02 points to 6,058.33. The NASDAQ Composite collected 13.1 points to 19,649.04. Shares of Meta Platforms and Tesla gained 2% and 5%, respectively, while Microsoft shares dipped more than 5% after the companies reported earnings. Meta beat on top and bottom lines, but Microsoft shares faltered after the company’s quarterly revenue forecast disappointed. Tesla shrugged off an earnings and revenue miss.Investors were also a bit cautious to buy after fourth-quarter GDP growth came in at just 2.3%, missing expectations.Other “Magnificent Seven” names are set to report in the coming days, with Apple’s results being due for a Thursday release. Amazon will soon follow suit, as the megacap tech company reports next week.Prices for the 10-year Treasury vaulted, lowering yields to 4.51% from Wednesday’s 4.55%. Treasury prices and yields move in opposite directions.Oil prices hiked 56 cents to $73.18 U.S. a barrel. Prices for gold brightened $45.00 an ounce to $2,838.50 U.S.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


